Patent Cliff Risk: Essential Guide to Pharma Revenue Exposure
Patent cliff risk is best analyzed as a revenue-replacement problem, not as a single patent-expiration date. For a pharmaceutical investor, the useful questions are how much revenue is concentrated in the protected product, when meaningful generic or biosimilar competition can actually begin, how quickly that revenue may erode, and whether other products can fill the … Read more